Brief: Sequent Scientific Gets WHO Prequalification Approval For Albendazole API
19/08/2024 12:54
Aug 19 (Reuters) - SeQuent Scientific Ltd SEQU.NS :
* GETS WHO PREQUALIFICATION APPROVAL FOR ALBENDAZOLE API
Source text for Eikon: ID:nBSE7BNkxd
Further company coverage: SEQU.NS
(Reporting by VijayDattaram Malkar)
((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India